In Brief Dana-Farber launches Center for RAS Therapeutics to target the RAS oncogene in cancer January 10, 2025Vol.51 No.01
In Brief Bertagnolli, Goldberg, Gunn, Brundage, and Theiler receive awards at Alliance fall meeting November 15, 2024Vol.50 No.43
Clinical Roundup AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution October 11, 2024Vol.50 No.38
Tumors are able to form with no DNA mutations, fly study shows September 13, 2024Vol.50 No.34By Jacquelyn Cobb
In Brief Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor September 06, 2024Vol.50 No.33
In Brief Nobel Laureate William Kaelin receives Fox Chases’s Stanley P. Reimann Honor Award April 05, 2024Vol.50 No.14
Trials & Tribulations Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry February 09, 2024Vol.50 No.06By Narjust Florez, Lauren Keil, Rebekah Kaufman and Oyepeju Abioye-Akintola
